Insulin Pump Market Size by Product Type (Tethered Pumps and Patch Pumps), By Accessories (Battery, Insulin Reservoir and Insulin Set Insertion Devices), By Distribution Channel (Online & Retail Pharmacy, Homecare, Hospitals & Clinics and Others) Regions, Segmentation, and forecast till 2030.
Pune India, Jan. 02, 2023 (GLOBE NEWSWIRE) — The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the insulin pump market is operating and is predicted to expand soon. The manufacturers and suppliers involved in the insulin pump market are present across various countries in the above-mentioned regions.
Get Sample Copy of This Report @ https://greyviews.com/reports/insulin-pump-market/321/request-sample
The report provides a detailed understanding of the market segments which have been formed by combining different prospects such as the type, accessories, distribution channel, and regions. Apart from this, the key driving factors, restraints, potential growth opportunities and market challenges are also discussed in the below paragraphs.
The significant players operating in the global insulin pump market are Medzer Ltd, Sooil Development, Valeritas, Inc, Tandem Diabetic Care, Inc, F. Hoffman-La Roche Ltd, Microtech Medical, Medtronic Plc, Eoflow, Vicentra B.V., Terumo Corporation, Cequer SA, Insulet Corporation, Microport Scientific, Ypsomed AG, Sanofi, Braun Melsungen AG, Becton among others. To achieve a substantial market share in the worldwide insulin pump market and strengthen their position, manufacturers are pursuing expansion methods such as current developments, mergers and acquisitions, product innovations, collaborations, and partnerships, joint ventures.
The insulin pump is designed to deliver doses of insulin to the body on a regular basis at regular intervals, depending on the consumer’s basal and bolus rates to control blood glucose levels. The global insulin pump market is also expected to grow due to increased product approvals, and various development strategies adopted by players, including distribution agreements, partnership agreements and collaborations. A large proportion of diabetes patients worldwide require insulin to manage their condition because of the growing prevalence of type-1 diabetes. Over the forecast period, diabetes patients’ increased awareness of these pumps and their associated benefits will drive the insulin pump market growth. The use of insulin pumps is widespread among patients who require multiple insulin injections daily because these devices are less intrusive. As diabetes management and care become more widely known and understood, electronic insulin pumps are becoming more popular among consumers and doctors alike. It is due to the fact that new-generation pumps provide accurate results and are convenient. A global push for greater awareness of medicare policies and diabetes management is also fueling the market growth. Furthermore, the market has grown continuously as people have become more aware of the disease due to the growing elderly population, as well as an increase in sedentary lifestyles.
Enquiry Before Buying This Report @ https://greyviews.com/inquiry/321
Scope of Insulin Pump Market Report:
Report Metric
Information
Study Period
2022-2030
Base Year
2022
Forecast Period
2023-2030
Market Share Unit
USD Billion
Segments Covered
Type, Accessories, Distribution Channel, and Regions.
Regions Covered
North America, Europe, Asia-Pacific, South America, and Middle-East and Africa
Major Players
Medzer Ltd, Sooil Development, Valeritas, Inc, Tandem Diabetic Care, Inc, F. Hoffman-La Roche Ltd, Microtech Medical, Medtronic Plc, Eoflow, Vicentra B.V., Terumo Corporation, Cequer SA, Insulet Corporation, Microport Scientific, Ypsomed AG, Sanofi, Braun Melsungen AG, Becton among others
Segmentation Analysis
Tethered pumps are expected to be the fastest-growing segment in 2022.
The type segment includes non-medical and medical. The tethered pumps segment is expected to witness the highest growth rate during the forecast period. Patients are increasingly using tethered insulin pumps because of their portability and convenience in carrying them. Moreover, the pumps can be synchronized with handsets to allow for easy control as well as monitoring of blood glucose levels, resulting in an increased demand for them.
Set insertion devices are expected to be the fastest-growing segment in 2022.
The accessories segment includes the battery, insulin reservoir and insulin set insertion devices. The set insertion devices segment is expected to witness the highest growth rate during the forecast period. Insulin set insertion devices held a dominant position in 2020 with a revenue share of 41%, primarily due to its high market share as infusion sets of insulin pumps are generally replaced every two or three days, and due to the high cost of infusion sets.
Online & retail pharmacy are expected to be the fastest-growing segment in 2022.
The distribution channel segment includes online & retail pharmacy, homecare, hospitals & clinics and others. The online & retail pharmacy segment is expected to witness the highest growth rate during the forecast period. With the increased availability of diabetes management devices in retail and pharmaceutical outlets in developed and developing nations, the retail & online pharmacy segment is a major driver of the insulin pump market.
Regional Analysis
The regional analysis provides a detailed perception of the key regions and the countries. Some of the key countries analyzed for insulin pumps include the US, Canada, Mexico, Germany, France, the U.K., Italy, Spain, Russia, China, Japan, India, Brazil, Peru, UAE, South Africa, and Saudi Arabia.
The North American region witnessed a major share. There are several major players in the insulin pump market in the region, as well as increasing obesity prevalence, high treatment costs, technological advancements, and product launches. Diabetes awareness and an increase in disposable income have spurred the adoption of insulin pumps among the population, propelling the growth of the market in the forecast period.
Country Analysis
Germany
Germany’s insulin pump market size was valued at USD 0.372 billion in 2021 and is expected to reach USD 1.25 billion by 2029, at a CAGR of 16.4% from 2023 to 2030.
There are several key players in the market there, and cutting-edge medical infrastructure, and technological advancements in the country propelling the growth of the insulin pump market.
China
China’s insulin pump market size was valued at USD 0.377 billion in 2021 and is expected to reach USD 1.27 billion by 2029, at a CAGR of 16.5% from 2023 to 2030.
Market growth is being fueled by the growing number of diabetes patients in the country. Moreover, rising healthcare expenditures by both government and private sectors will enhance the market’s growth.
India
India’s insulin pump market size was valued at USD 0.29 billion in 2021 and is expected to reach USD 0.99 billion by 2029, at a CAGR of 16.6% from 2023 to 2030.
Increased elderly populations, diabetes incidence, and obesity rates are some of the factors driving the market growth in the country. Furthermore, increasing technological advancement in insulin pumps will add more value to the growth of the market in future.
Covid-19 Impact
Covid-19 had a major impact on almost all industries, such as electronics, semiconductors, manufacturing, automobile, etc. However, several companies operating in the technology sector have seen increased revenue due to significant changes in consumer preferences toward technological services. In addition, the pandemic has led to significant growth in technology across developing and developed countries.
Furthermore, the growth of this market is mainly driven owing to the increasing demand from the healthcare segment for diabetes patients across countries.
Buy Now Full Report @ https://greyviews.com/checkout/321/single_user_license
Contact Us
Rocky Shah
GreyViews
Pune India
Phone: (+44) 162-237-1047
Email: sales@greyviews.com
Web: https://greyviews.com/
Follow Us: LinkedIn | Twitter
Browse Related Reports:
Disposable Syringes Market Size By Product (Conventional Syringes and Safety Syringes), By Application (Immunization Injections and Therapeutic Injections), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/disposable-syringes-market/351
Bipolar Disorder Market Size By Drug Class (Anticonvulsant, Mood Stabilizer, Antidepressant Drug, Antipsychotic Drug, and Others), By Mechanism of Action (Serotonin Norepinephrine Reuptake Inhibitor, Selective Serotonin Reuptake Inhibitor, Beta Blockers, Tricyclic Antidepressant Drug, and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/bipolar-disorder-market/350
Prostate Cancer Diagnostics Market Size By Test Type (Confirmatory and Preliminary), By End-User (Cancer Research Institutes, Hospital Associated Laboratories and Independent Diagnostics Laboratories), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/prostate-cancer-diagnostics-market/334
Human Insulin Market Size By Type (Traditional Human Insulin and Modern Human Insulin), By Distribution Channel (Hospitals, Retail Pharmacies, And Others), By Application (Type 1 Diabetes and Type 2 Diabetes), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/human-insulin-market/333
Human Insulin Drugs and Delivery Devices Market Size By Product Type (Human Insulin Delivery Devices and Human Insulin Drugs), By Delivery Device (Insulin Pumps, Insulin Injectors, Insulin Pens and Insulin Syringes), By End-User (Homecare, Hospitals, Specialty Clinics and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/human-insulin-drugs-and-delivery-devices-market/332
Emesis Bags Market Size By Type (Paper, Plastic and Others), By Application (Medical, Road Transport, Water Transport, Air Transport, and Others), By Patient (Adults and Pediatrics), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/emesis-bags-market/326
Digital Hearing Aids Market Size By Technology (Digital and Conventional), By Type of Hearing Loss (Conductive, Sensorineural and Others), By Distribution Channel (E-Commerce, Retail Stores and Others), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/digital-hearing-aids-market/325
Insulin Pump Market Size by Product Type (Tethered Pumps and Patch Pumps), By Accessories (Battery, Insulin Reservoir and Insulin Set Insertion Devices), By Distribution Channel (Online & Retail Pharmacy, Homecare, Hospitals & Clinics and Others) Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/insulin-pump-market/321
Cardiac Catheters Market Size By Type (Electrophysiology Catheters, IVUS Catheters, PTA Balloons Catheters, PTCA Balloons Catheters, and Others), By End-User (Clinics, Public Ambulatory Surgical Centers, Hospitals, and Others) Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/cardiac-catheters-market/318
Telehealth Market Size By Product Type (Software, Hardware, and Services), By Delivery Mode (Web-based, On-premise, and Cloud-based), By End-User (Patients, Providers, and Payers), Regions, Segmentation, and Projection till 2030
https://greyviews.com/reports/telehealth-market/316
Is China's regulatory crackdown on private-sector companies easing, or continuing? The market on Tuesday seemed to think the former, [as most Chinese stocks rose](https://www.wsj.com/livecoverage/stock-market-news-today-01-03-2023/card/chinese-stocks-start-2023-on-firmer-footing-dqWNwXe78DjgfRz1OKIn) on the first trading day of 2023. On Friday, China's securities regulator said two Nasdaq-listed retail brokers, Up Fintech and Futu, had [unlawfully allowed Chinese citizens to trade overseas](http
Or is it just hot air?
Eli Lilly's (NYSE: LLY) biosimilar drug known as Rezvoglar was given the green light by the U.S. Food and Drug Administration (FDA) to be marketed as an interchangeable to Sanofi's (NASDAQ: SNY) Lantus long-acting insulin. This follows the FDA's approval of Rezvoglar as a biosimilar last December. What prompted the FDA to make Rezvoglar the second interchangeable biosimilar to Sanofi's Lantus behind Viatris' (NASDAQ: VTRS) Semglee?
Roche Holding (OTC: RHHBY) and Gilead Sciences (NASDAQ: GILD) both saw increased sales during the pandemic, due in part to their COVID-19 products. For Gilead, it was its COVD-19 antiviral, Veklury, and for Roche, its revenue was boosted mostly by coronavirus tests. Gilead's shares have glittered in 2022, with the stock up more than 16%, while Roche's have fallen more than 23% so far this year.
Schlumberger, Halliburton, RPC and ProPetro have been highlighted in this Industry Outlook article.
We asked 3 experts to explain every wise move you should make regarding how to walk, what shoes you need and how much to walk to feel fantastic, inside and out.
Skip the fad diets and expensive fitness gear you’ll never use this year.
Long COVID not only causes lingering symptoms from the initial infection with many people, but it can be deadly too. According to a new analysis of death certificates from the Centers for Disease Control and Prevention, long Covid has caused or contributed to at least 3,500 deaths in the United States. "It's not one of the leading causes of death, but, considering that this is the first time that we've looked at it and that long Covid is an illness that we're learning more about day after day, t
10,000 may be an arbitrary number, but the daily step goal has helped improve my mental and physical health
FUTURES MOVERS Oil futures traded lower Tuesday to kick off the new year, reflecting continued worries that surging COVID-19 cases in China will crimp demand from one of the world’s largest energy consumers.
With PepsiCo at the top of the pile, these are the 10 largest beverage companies by 12-month trailing revenue.
Research from Tufts University shows that certain foods often considered unhealthy are more nutritious than some might expect
A new strain of COVID-19 has taken hold in the Northeastern U.S., according to the Centers for Disease Control and Prevention. The subvariant of omicron, named XBB.1.5, has doctors concerned about another potential wave of COVID-19 cases following the busy holiday travel season. The CDC projected about 40% of confirmed U.S. COVID-19 cases are caused by this new strain.
A faster pace showed positive outcomes for heart disease, cancer, dementia and death, over and above the total number of daily steps taken
(Bloomberg) — Swedish oat milk maker Oatly Group AB will transfer leases and production capacity at two US facilities to Canadian manufacturer Ya YA Foods Corp. in a co-packing agreement that is part of its shift to an “asset-light” supply-chain strategy, the companies announced in a joint statement on Tuesday. Most Read from BloombergElon Musk Becomes First Person Ever to Lose $200 BillionChina’s Foreign Minister Says ‘Deeply Impressed’ With AmericansUkraine Latest: Strike Kills 63 Russian Tro
Oil prices edged lower on Tuesday in volatile trade as weak demand data from China and a gloomy economic outlook weighed.
Ethereum's Shanghai upgrade is set to de-risk ether staking by allowing ETH withdrawals. That's likely to pave the way for widespread adoption of liquid staking solutions.
The airline industry is long overdue for a tech overhaul that takes full advantage of the cloud and data integration, analysts say.
Actor Jeremy Renner is out of surgery on Monday after he was injured while plowing snow on Sunday, according to his publicist. "We can confirm that Jeremy has suffered blunt chest trauma and orthopedic injuries and has undergone surgery today," his publicist said in a statement Monday evening. "He has returned from surgery and remains in the intensive care unit in critical but stable condition."
A Green Bay native spent the last 20 years studying Eastern medical practices in China. He's returned to open an acupuncture clinic in his hometown.